![CRISPR/Cas Multiplexed Biosensing: A Challenge or an Insurmountable Obstacle?: Trends in Biotechnology CRISPR/Cas Multiplexed Biosensing: A Challenge or an Insurmountable Obstacle?: Trends in Biotechnology](https://www.cell.com/cms/attachment/c5ac31a8-48f5-4cf3-bc85-0860ff1661ca/gr1.jpg)
CRISPR/Cas Multiplexed Biosensing: A Challenge or an Insurmountable Obstacle?: Trends in Biotechnology
![Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial - Journal of Thrombosis and Haemostasis Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial - Journal of Thrombosis and Haemostasis](https://www.jthjournal.org/cms/asset/7179742a-c20d-4649-bca9-0b58d5df50bc/JTH_2748_f1.jpg)
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial - Journal of Thrombosis and Haemostasis
![Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint - eBioMedicine Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint - eBioMedicine](https://www.thelancet.com/cms/attachment/c3c2db3a-1f66-4430-a72c-cb36321b7f38/gr1.jpg)